Lixte Biotechnology Holdings, Inc. Announces Closing of Public Offering and Uplisting to Nasdaq
The shares and warrants were immediately separable, were issued separately, and began trading on The Nasdaq Capital Market on Wednesday, November 25, 2020, under the symbols LIXT and LIXTW, respectively.
- The shares and warrants were immediately separable, were issued separately, and began trading on The Nasdaq Capital Market on Wednesday, November 25, 2020, under the symbols LIXT and LIXTW, respectively.
- WestPark Capital, Inc. and WallachBeth Capital, LLC acted as the joint book-running managers for the offering.
- TroyGould PC acted as the Company'slegal counsel andSheppard, Mullin, Richter & Hampton, LLPacted aslegal counsel for the joint book-running managers.
- This discussion should be read in conjunction with the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov .